Our finding of an association between a CD34‐positive CD38 dim‐positive LAIP and poor therapy response raises the question whether this LAIP represents a less differentiated, stem‐like, and therapy‐resistant leukemic phenotype, as seen for CD34‐positive CD38‐negative leukemic cells in AML [57]. This evidence concerns the gene CD38 and acute myeloid leukemia.